A Bioinformatics Approach to the Identification of Variants Associated with Type 1 and Type 2 Diabetes Mellitus that Reside in Functionally Validated miRNAs Binding Sites

Biochemical Genetics

Volumn 54, Issue 3, 2016, Pages 211-221

  Ghaedi, Hamid ^a   Bastami, Milad ^a   Jahani, Mohammad Mehdi ^b   Alipoor, Behnam ^c   Tabasinezhad, Maryam ^d   Ghaderi, Omar ^e   Nariman Saleh Fam, Ziba ^c   Mirfakhraie, Reza ^a   Movafagh, Abolfazl ^a   Omrani, Mir Davood ^a   Masotti, Andrea ^f  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d PASTEUR INSTITUTE OF IRAN   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Diabetes mellitus; Genome wide association study; MicroRNA; Single nucleotide polymorphism; Target site

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 135B 5P; MICRORNA 139 5P; MICRORNA 146A; MICRORNA 146A 5P; MICRORNA 146B 5P; MICRORNA 204 5P; MICRORNA 210; MICRORNA 210 3P; MICRORNA 211 5P; MICRORNA 222 3P; MICRORNA 302A 3P; MICRORNA 302B 3P; MICRORNA 302C 3P; MICRORNA 302D 3P; MICRORNA 30A 5P; MICRORNA 30B 5P; MICRORNA 30C 5P; MICRORNA 30D 5P; MICRORNA 30E 5P; MICRORNA 325 5P; MICRORNA 375; MICRORNA 381 3P; MICRORNA 520A 3P; MICRORNA 520B; MICRORNA 520C 3P; MICRORNA 520D 3P; MICRORNA 520E; MICRORNA 7 5P; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BINDING SITE; BIOINFORMATICS; CELL GROWTH; CELL PROLIFERATION; EPIGENETICS; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HUMAN; INDEL MUTATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; RNA BINDING; SINGLE NUCLEOTIDE POLYMORPHISM; BIOLOGY; CHEMISTRY; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PROCEDURES;

BINDING SITES; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER;

EID: 84955599201     PISSN: 00062928     EISSN: 15734927     Source Type: Journal    
DOI: 10.1007/s10528-016-9713-5     Document Type: Article

References (49)

1. Ambros V (2004) The functions of animal microRNAs. Nature 431:350–355
2. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
3. Baxter AG, Jordan MA (2011) From markers to molecular mechanisms: type 1 diabetes in the post-GWAS era. Rev Diabet Stud 9:201–223
4. Bhattacharya A, Ziebarth JD, Cui Y (2014) PolymiRTS Database 3.0: linking polymorphisms in microRNAs and their target sites with human diseases and biological pathways. Nucleic Acids Res 42:D86–D91
5. Bulik-Sullivan B, Selitsky S, Sethupathy P (2013) Prioritization of genetic variants in the microRNA regulome as functional candidates in genome-wide association studies. Hum Mutat 34:1049–1056
6. Bushati N, Cohen SM (2007) MicroRNA functions. Annu Rev Cell Dev Biol 23:175–205
7. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857–866
8. Chen K, Song F, Calin GA, Wei Q, Hao X, Zhang W (2008) Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis 29:1306–1311
9. Ciccacci C et al (2013) MicroRNA genetic variations: association with type 2 diabetes. Acta Diabetol 50:867–872
10. Consortium GP (2012) An integrated map of genetic variation from 1092 human genomes. Nature 491:56–65
11. Cui Y (2014) In silico mapping of polymorphic miRNA-mRNA interactions in autoimmune thyroid diseases. Autoimmunity 47(5):327–333
12. Edwards SL, Beesley J, French JD, Dunning AM (2013) Beyond GWASs: illuminating the dark road from association to function. Am J Hum Genet 93:779–797
13. Ficarra E (2012) One decade of development and evolution of microRNA target prediction algorithms. Genom Proteom Bioinform 10:254–263
14. Guay C, Regazzi R (2013) Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol 9:513–521
15. Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R (2011) Diabetes mellitus, a microRNA-related disease? Transl Res 157:253–264
16. Hafner M et al (2010) Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141:129–141
17. Helwak A, Kudla G, Dudnakova T, Tollervey D (2013) Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153:654–665
18. Herrera B et al (2010) Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia 53:1099–1109
19. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci 106:9362–9367
20. Kanehisa M, Goto S (2000) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28:27–30
21. Kloosterman WP, Plasterk RH (2006) The diverse functions of microRNAs in animal development and disease. Dev Cell 11:441–450
22. Li J, Zhang Z (2013) miRNA regulatory variation in human evolution. Trends Genet 29:116–124
23. Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X (2010) Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes care 33:1872–1894
24. Lovis P et al (2008) Alterations in microRNA expression contribute to fatty acid–induced pancreatic β-cell dysfunction. Diabetes 57:2728–2736
25. Lu J, Clark AG (2012) Impact of microRNA regulation on variation in human gene expression. Genome Res 22:1243–1254
26. Madhyastha R, Madhyastha H, Nakajima Y, Omura S, Maruyama M (2012) MicroRNA signature in diabetic wound healing: promotive role of miR-21 in fibroblast migration. Int Wound J 9:355–361
27. Meola N, Gennarino VA, Banfi S (2009) microRNAs and genetic diseases. Pathogenetics 2:7
28. Nesca V et al (2013) Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes. Diabetologia 56:2203–2212
29. Nielsen LB et al (2012) Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression. Exp Diabetes Res 2012:896362
30. Osipova J et al (2014) Diabetes-associated microRNAs in pediatric patients with type 1 diabetes mellitus: a cross-sectional cohort study. J Clin Endocrinol Metab 99:E1661–E1665
31. Pasquinelli AE (2012) MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 13:271–282
32. Poy MN et al (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432:226–230
33. Poy MN et al (2009) miR-375 maintains normal pancreatic α-and β-cell mass. Proc Natl Acad Sci 106:5813–5818
34. Prentki M, Nolan CJ (2006) Islet β cell failure in type 2 diabetes. J Clin Investig 116:1802–1812
35. Roggli E, Gattesco S, Caille D, Briet C, Boitard C, Meda P, Regazzi R (2012) Changes in microRNA expression contribute to pancreatic β-cell dysfunction in prediabetic NOD mice. Diabetes 61:1742–1751
36. Ryan BM, Robles AI, Harris CC (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10:389–402
37. Salas-Pérez F, Codner E, Valencia E, Pizarro C, Carrasco E, Pérez-Bravo F (2013) MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes. Immunobiology 218:733–737
38. Sayed D, Abdellatif M (2011) MicroRNAs in development and disease. Physiol Rev 91:827–887
39. Sebastiani G, Grieco FA, Spagnuolo I, Galleri L, Cataldo D, Dotta F (2011) Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity. Diabetes/Metab Res Rev 27:862–866
40. Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P, Lauro R (2001) Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J 15:2099–2111
41. Shantikumar S, Caporali A, Emanueli C (2012) Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res 93:583–593
42. Taylor J, Schenck I, Blankenberg D, Nekrutenko A (2007) Using galaxy to perform large-scale interactive data analyses. Curr Protoc Bioinform. 10:10.5. doi:10.1002/0471250953.bi1005s19
43. Trajkovski M et al (2011) MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474:649–653
44. Wang Y, Liu J, Liu C, Naji A, Stoffers DA (2013) MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic β-cells. Diabetes 62:887–895
45. Ward LD, Kellis M (2012) HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 40:D930–D934
46. Welter D et al (2014) The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 42:D1001–D1006
47. Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–321
48. Yang J-H, Li J-H, Shao P, Zhou H, Chen Y-Q, Qu L-H (2011) starBase: a database for exploring microRNA–mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res 39:D202–D209
49. Zampetaki A et al (2010) Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107:810–817